Abstract
The literature on risk factors for gestational diabetes mellitus recurrence is inconsistent and sometimes contradictory. The importance of inter-pregnancy interval and parity, remains unclear. We aimed to explore controversial risk factors for gestational diabetes mellitus recurrence, especially the modifiable ones, and to develop a prediction model in a cohort of women with gestational diabetes mellitus. A retrospective, population-based, cross-sectional cohort study was performed. The study included 788 women with gestational diabetes mellitus that delivered between 1991–2012 and had consecutive deliveries at a university affiliated hospital in Israel. Women with pre-existing diabetes were excluded. Factors associated with gestational diabetes mellitus recurrence were examined using log-binomial models to estimate prevalence ratios with 95 % confidence intervals. Multivariate analysis revealed that both inter-pregnancy interval and multiparity were significant risk factors for gestational diabetes mellitus recurrence. Other significant risk factors were maternal age, gestational diabetes mellitus diagnosis week, oral glucose tolerance test values, body mass index gain between pregnancies and insulin use; the latter and multiparity had the strongest effect size (PR ≥ 1.2). Among multiparous women, the association between inter-pregnancy interval and gestational diabetes mellitus recurrence was significantly lower (P = 0.0004) compared with primiparous women (PR = 1.11 [95 % CI 1.09–1.13] versus PR = 1.17 [95 % CI 1.15–1.20], respectively). The model we developed, predicts that reducing the inter-pregnancy interval and weight gain between pregnancies can reduce substantially the risk of gestational diabetes mellitus recurrence. The results suggest that weight gain and inter-pregnancy interval are modifiable risk factors for gestational diabetes mellitus recurrence. Our model could assist physicians in advising women with gestational diabetes mellitus in reducing the risk of recurrent gestational diabetes mellitus during subsequent pregnancies.
Similar content being viewed by others
References
American Diabetes Association, Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 32(Supplement_1), S62–S67 (2009)
B.E. Metzger, D.R. Coustan, Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 21(Suppl 2), B161–B167 (1998)
A. Ferrara, H.S. Kahn, C.P. Quesenberry, C. Riley, M.M. Hedderson, An Increase in the Incidence of Gestational Diabetes Mellitus: Northern California, 1991–2000. Obstet Gynecol 103(3), 526–533 (2004)
N.A. Beischer, J.N. Oats, O.A. Henry, M.T. Sheedy, J.E. Walstab, Incidence and Severity of Gestational Diabetes Mellitus According to Country of Birth in Women Living in Australia. Diabetes 40(Supplement_2), 35–38 (1991)
B.E. Metzger, Long-term outcomes in mothers diagnosed with gestational diabetes mellitus and their offspring. Clin Obstet Gynecol 50(4), 972–979 (2007)
N. Schwartz, Z. Nachum, M.S. Green, The prevalence of gestational diabetes mellitus recurrence-effect of ethnicity and parity: a metaanalysis. Am J Obstet Gynecol 213(3), 310–317 (2015)
J.R. Steinhart, J.R. Sugarman, F.A. Connell, Gestational diabetes is a herald of NIDDM in Navajo women. High rate of abnormal glucose tolerance after GDM. Diabetes Care 20(6), 943–947 (1997)
F. Pallardo, L. Herranz, T. Garcia-Ingelmo, C. Grande, P. Martin-Vaquero, M. Jañez, A. Gonzalez, Early postpartum metabolic assessment in women with prior gestational diabetes. Diabetes Care 22(7), 1053–1058 (1999)
N. Schwartz, Z. Nachum, M. S. Green, Risk factors of gestational diabetes mellitus recurrence: a meta-analysis. Endocrine 1–10 (2016). [Epub ahead of print]
C.A. Major, M. deVeciana, J. Weeks, M.A. Morgan, Recurrence of gestational diabetes: who is at risk?. Am J Obstet Gynecol 179(4), 1038–1042 (1998)
T. Nohira, S. Kim, H. Nakai, K. Okabe, T. Nohira, K. Yoneyama, Recurrence of gestational diabetes mellitus: rates and risk factors from initial GDM and one abnormal GTT value. Diabetes Res Clin Pract 71(1), 75–81 (2006)
H.J. Holmes, J.Y. Lo, D.D. McIntire, B.M. Casey, Prediction of diabetes recurrence in women with class A1 (diet-treated) gestational diabetes. Am J Perinatol 27(1), 47–52 (2010)
A.Z. Khambalia, J.B. Ford, N. Nassar, A.W. Shand, A. McElduff, C.L. Roberts, Occurrence and recurrence of diabetes in pregnancy. Diabet Med J Br Diabet Assoc 30(4), 452–456 (2013)
C.V. Ananth, Epidemiologic Approaches for Studying Recurrent Pregnancy Outcomes: Challenges and Implications for Research. Semin Perinatol 31(3), 196–201 (2007)
S. Mizrahi, N. Cohen, Privatization Through Centralization in the Israeli Health Care System The Case of the National Health Insurance Law and its Amendments. Adm Soc 44(4), 412–437 (2012)
M.W. Carpenter, D.R. Coustan, Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144(7), 768–773 (1982)
Group NDD, Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance. Diabetes 28(12), 1039–1057 (1979)
O. Langer, L. Brustman, A. Anyaegbunam, R. Mazze, The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy. Am J Obstet Gynecol 157(3), 758–763 (1987)
O. Langer, A. Anyaegbunam, L. Brustman, M. Divon, Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 161(3), 593–599 (1989)
J.A. Deddens, M.R. Petersen, Approaches for estimating prevalence ratios. Occup Environ Med 65(7), 501–506 (2008)
R.K. Peters, S.L. Kjos, A. Xiang, T.A. Buchanan, Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus. Lancet 347(8996), 227–230 (1996)
E.H. Philipson, D.M. Super, Gestational diabetes mellitus: does it recur in subsequent pregnancy?. Am J Obstet Gynecol 160(6), 1324–1331 (1989)
D. Getahun, M.J. Fassett, S.J. Jacobsen, Gestational diabetes: risk of recurrence in subsequent pregnancies. Am J Obstet Gynecol 203(5), 467 (2010). e1-6
S.F. Ehrlich, M.M. Hedderson, J. Feng, E.R. Davenport, E.P. Gunderson, A. Ferrara, Change in body mass index between pregnancies and the risk of gestational diabetes in a second pregnancy. Obstet Gynecol 117(6), 1323–1330 (2011)
N.B. Anderson, R.A. Bulatao, B. Cohen, National Research Council (US) Panel on Race E. Race/Ethnicity, Socioeconomic Status, and Health. 2004, http://www.ncbi.nlm.nih.gov/books/NBK25526/. Accessed 3 Oct 2014
C. Kim, D.K. Berger, S. Chamany, Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care 30(5), 1314–1319 (2007)
J.N. Bottalico, Recurrent Gestational Diabetes: Risk Factors, Diagnosis, Management, and Implications. Semin Perinatol 31(3), 176–184 (2007)
A. Lindquist, N. Noor, E. Sullivan, M. Knight, The impact of socioeconomic position on severe maternal morbidity outcomes among women in Australia: a national case-control study. BJOG Int J Obstet Gynaecol 122(12), 1601–1609 (2014)
International Association of Diabetes and Pregnancy Study Groups Consensus Panel, B.E. Metzger, S.G. Gabbe, B. Persson, T.A. Buchanan, P.A. Catalano et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33, 676–682 (2010)
D.A. Sacks, D.R. Hadden, M. Maresh, C. Deerochanawong, A.R. Dyer, B.E. Metzger et al. Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria. Diabetes Care 35(3), 526–528 (2012)
Acknowledgments
We thank Emek Medical Center, Afula, Israel, for the technical support in this study. We would like to thank Mrs. Snait Ayalon for her kind assistance in data mining.
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interests.
Ethical approval
Emek medical center ethics committee approval number EMC0061-13.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Schwartz, N., Green, M.S., Yefet, E. et al. Modifiable risk factors for gestational diabetes recurrence. Endocrine 54, 714–722 (2016). https://doi.org/10.1007/s12020-016-1087-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-016-1087-2